Vik Chopra
Stock Analyst at Wells Fargo
(3.12)
# 1,145
Out of 5,241 analysts
68
Total ratings
44.83%
Success rate
3.98%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Maintains: Equal-Weight | $86 → $83 | $74.26 | +11.77% | 6 | Feb 27, 2026 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $13 → $12 | $14.10 | -14.89% | 3 | Feb 27, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $12 → $13 | $10.07 | +29.10% | 5 | Feb 27, 2026 | |
| GMED Globus Medical | Maintains: Overweight | $98 → $104 | $76.64 | +35.70% | 12 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Equal-Weight | $76 → $87 | $72.72 | +19.64% | 4 | Feb 25, 2026 | |
| MASI Masimo | Downgrades: Equal-Weight | $190 → $180 | $178.44 | +0.87% | 11 | Feb 18, 2026 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $21 → $26 | $23.22 | +11.97% | 4 | Feb 6, 2026 | |
| ALGN Align Technology | Maintains: Overweight | $181 → $200 | $157.25 | +27.19% | 5 | Feb 5, 2026 | |
| CNMD CONMED | Maintains: Equal-Weight | $41 → $42 | $35.49 | +18.34% | 7 | Jan 29, 2026 | |
| ENOV Enovis | Maintains: Overweight | $41 → $42 | $24.29 | +72.91% | 5 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $16 | $15.36 | +4.17% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $16 | $7.66 | +108.88% | 2 | Oct 16, 2025 |
Solventum
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $86 → $83
Current: $74.26
Upside: +11.77%
Integra LifeSciences Holdings
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $13 → $12
Current: $14.10
Upside: -14.89%
DENTSPLY SIRONA
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $10.07
Upside: +29.10%
Globus Medical
Feb 26, 2026
Maintains: Overweight
Price Target: $98 → $104
Current: $76.64
Upside: +35.70%
Henry Schein
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $76 → $87
Current: $72.72
Upside: +19.64%
Masimo
Feb 18, 2026
Downgrades: Equal-Weight
Price Target: $190 → $180
Current: $178.44
Upside: +0.87%
Envista Holdings
Feb 6, 2026
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $23.22
Upside: +11.97%
Align Technology
Feb 5, 2026
Maintains: Overweight
Price Target: $181 → $200
Current: $157.25
Upside: +27.19%
CONMED
Jan 29, 2026
Maintains: Equal-Weight
Price Target: $41 → $42
Current: $35.49
Upside: +18.34%
Enovis
Nov 7, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $24.29
Upside: +72.91%
Nov 5, 2025
Maintains: Overweight
Price Target: $15 → $16
Current: $15.36
Upside: +4.17%
Oct 16, 2025
Maintains: Overweight
Price Target: $14 → $16
Current: $7.66
Upside: +108.88%